The Food and Drug Administration has approved a drug to combat non-Hodgkin's lymphoma. That's good news for cancer patients in America and around the world. But you wouldn't know it, given the vicious political campaign being directed against the pharmaceutical industry.

America's drug makers are under attack. Congressmen would like to cut prices, and the expansion of Medicare will encourage Uncle Sam to regulate drug access and prices directly.

State legislators are debating their own draconian price-control schemes. The media, such as the PBS show "Frontline," have targeted the drug makers. Trial attorneys, left-wing activists, and state attorneys general arc filing lawsuits charging ...

Related newspaper, magazine, and journal articles:

;

See all results. Or, try our Advanced Search.

We're searching over:

• 60 million articles
• 3,500 publications